Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
Assem H. Eldeeb, Mahmoud F. Abo-Ashour, Andrea Angeli, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113486-113486
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors
Derya Osmani̇ye, Cüneyt Türkeş, Yeliz Demir, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 8
Closed Access | Times Cited: 65
Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors
Aida Buza, Cüneyt Türkeş, Mustafa Arslan, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124232-124232
Closed Access | Times Cited: 60
Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6359-6377
Closed Access | Times Cited: 44
Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 12, pp. 1197-1208
Closed Access | Times Cited: 68
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1278-1298
Open Access | Times Cited: 63
Development of novel indolin-2-one derivative incorporating thiazole moiety as DHFR and quorum sensing inhibitors: Synthesis, antimicrobial, and antibiofilm activities with molecular modelling study
Abdullah Yahya Abdullah Alzahrani, Yousry A. Ammar, Mohammed Abu‐Elghait, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105571-105571
Closed Access | Times Cited: 59
Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach
Haytham O. Tawfik, Andrea Petreni, Claudiu T. Supuran, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114190-114190
Closed Access | Times Cited: 44
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 6
Substituted pyrazole derivatives as potential fungicidal agents
Daye Huang, Fang Liu, Shaohua Wen, et al.
Phytochemistry Letters (2024) Vol. 59, pp. 117-123
Closed Access | Times Cited: 3
Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Amit Kumar, Kiran Siwach, Tanmay Rom, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105764-105764
Closed Access | Times Cited: 19
Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents
Haytham O. Tawfik, Amany Belal, Mohammed A. S. Abourehab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2765-2785
Open Access | Times Cited: 19
Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations
Arif Mermer, Burak Tüzün, Sevgi Durna Daştan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 11
Open Access | Times Cited: 8
Enzyme Inhibition Properties and Molecular Docking Studies of 4‐Sulfonate Containing Aryl α‐Hydroxyphosphonates Based Hybrid Molecules
İrfan Şahin, Zeynebe Bingöl, Sultan Onur, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 5
Closed Access | Times Cited: 13
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers
Eman M. H. Abbas, Thoraya A. Farghaly, Rehab Sabour, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 13
Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents
Ahmed F. Khalil, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 7
Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases
Baijayantimala Swain, Santosh K. Sahoo, Priti Singh, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114247-114247
Closed Access | Times Cited: 12
Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment
Mahmoud F. Abo-Ashour, Hadia Almahli, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2256-2264
Open Access | Times Cited: 9
Design, synthesis, and biological evaluation of 3‐benzenesulfonamide‐linked 3‐hydrazinoisatin derivatives as carbonic anhydrase inhibitors
Baijayantimala Swain, Vaibhav S. Marde, Priti Singh, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Closed Access | Times Cited: 1
تحضير وتشخيص و ودراسة النشاط البيولوجي والالتحام الجزيئي لبعض مشتقات السلفاميثوكسازول الجديدة.
Athra G. Sager, Jawad Kadhim Abaies, Rusul Abdulridah Issa
Baghdad Science Journal (2024) Vol. 21, Iss. 11, pp. 3411-3427
Open Access | Times Cited: 1
Benzothiazole derivatives in the design of antitumor agents
Niccolò Paoletti, Claudiu T. Supuran
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access | Times Cited: 1
Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward hCA IX/XII, facilitating anticancer drug development
Monalisa Mahapatra, Suman Kumar Mekap, Suvadeep Mal, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 4
Closed Access | Times Cited: 4
Naturbasierte bioinformatische Ansätze in der Arzneimittelforschung gegen vielversprechende molekulare Ziele – Carbonanhydrasen und Serin/Threonin-Kinasen zur Krebsbehandlung
Mudasir Nabi Peerzada, Masood Ahmad Rizvi, K.K. Ajeeshkumar, et al.
(2024), pp. 343-363
Closed Access
Targeting Periplakin of Novel Benzenesulfonamides as Highly Selective Agonists for the Treatment of Vitiligo
Hui Zhong, Panpan Li, Qiuming Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19323-19341
Closed Access
Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights
Nafeesa Naeem, Amina Sadiq, Mohamed I. A. Othman, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35769-35970
Open Access
One-pot photo-biocatalytic cascade reactions for enantioselective synthesis of β-hydroxy sulfones
E Dongxiao, Jing You, Yang Zong, et al.
Molecular Catalysis (2024) Vol. 572, pp. 114778-114778
Closed Access
Page 1 - Next Page

Scroll to top